Science & Technology
A Platform to Identify Antifungal Compounds with Novel Action Mechanisms
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R43AI179388-01
Award Ceiling
$300K
Award Floor
$300K
Close Date
Jun 30, 2024
Total Funding
$300K
Expected Awards
1
Posted Date
Jul 19, 2023
Cost Sharing Required
No
Grants.gov ID
sbir-1R43AI179388-01
Description
SBIR Phase Phase I award: "A Platform to Identify Antifungal Compounds with Novel Action Mechanisms" awarded to INTACT GENOMICS INC in SAINT LOUIS, Missouri. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $300,156. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, Socially/economically disadvantaged
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.